John Poulos is a Gastroenterology physician affiliated with Cumberland Research Associates. OpenAlex indexes 57 publications with 3,507 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2041 Valleygate Dr
Fayetteville, NC 283043688
Telephone
910-323-5203Registry record last updated 30 Aug 2019.
Clinical trials
- Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)
Sponsor: Biovil Research Group, LLC
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202523 payments$56,554openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202523 payments$17,255openpaymentsdata.cms.gov ↗
- Madrigal PharmaceuticalsProgram year20259 payments$10,268openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
86.2%Proton pump inhibitor43.8%Omeprazole59%Rabeprazole Sodium29%Pantoprazole Sodium9%Esomeprazole Magnesium3%Part D<11 patientsGuanylate Cyclase-C Agonist15.9%Linzess100%Part D≥38 patients+ 11 more classes in this area
Cancer & immunology
4.1%TNF inhibitor2.5%Humira Pen100%Part D<11 patientsPurine Antimetabolite1.6%Azathioprine100%Part D<11 patientsRespiratory
3.4%Corticosteroid1.8%Budesonide Dr100%Part D<11 patientsPhenothiazine1.6%Promethazine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”